(Q36088772)

12 August 2017

1 reference

title

New pharmacological approaches to the management of depression: from theory to clinical practice (English)

1 reference

12 August 2017

T R Norman

1

1 reference

PubMed ID

1580888

12 August 2017

F K Judd

series ordinal

2

1 reference

PubMed ID

1580888

12 August 2017

G D Burrows

series ordinal

3

1 reference

12 August 2017

1 March 1992

1 reference

Australian and New Zealand Journal of Psychiatry

12 August 2017

1 reference

12 August 2017

26

1 reference

12 August 2017

73-81

1 reference

12 August 2017

1

1 reference

The treatment of depressive states with G 22355 (imipramine hydrochloride).

12 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F00048679209068311

Antidepressant drugs and down-regulation of presynaptic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679209068311

Down-regulation of beta-adrenergic receptors following repeated injections of desmethylimipramine: permissive role of serotonergic axons.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679209068311

Desipramine-yohimbine combination treatment of refractory depression. Implications for the beta-adrenergic receptor hypothesis of antidepressant action

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679209068311

Neurotransmitter receptors and phosphoinositide turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679209068311

Do antidepressants possess a common mechanism of action?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679209068311

Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679209068311

Minaprine: an anticholinergic-free antidepressant? Results of a controlled trial of mianserin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679209068311

Short-acting novel MAO inhibitors: in vitro evidence for the reversibility of MAO inhibition by moclobemide and Ro 16-6491.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679209068311

Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679209068311

10.3109/00048679209068311

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

1580888